Poland - Pharmaceutical products
For more information and to make a bid you will need to go to the third party website.
Details
Provided by
- Opportunity closing date
- 17 July 2019
- Opportunity publication date
- 13 June 2019
- Category
- 33600000: Pharmaceutical products
- Value of contract
- £1m-5m
- Your guide to exporting
Description
The subject of the contract is the delivery of: 1. Carboplatin (10 mg/5 ml) - 1 000 pieces2. Carboplatin (10 mg/15 ml) - 800 pieces3. Carboplatin (10 mg/45 ml) - 500 pieces4. Carboplatin (10 mg/60 ml) - 1500 piecesThe detailed description of the subject of the contract is included in Appendix 1a to the specification. Doxorubicin (dose 50 mg x 2 sets of 3 vials each) - 300 setsDetailed description of the subject of the order can be found in attachment 1a to the specification. The subject of the contract is the delivery of: 1. Cytarabinum (dose 100 mg) - 400 pieces2. Cytarabinum (500 mg dose) - 400 piecesThe detailed description of the subject of the contract is attached as Appendix 1a to the specification. The subject of the contract is the delivery of: 1. Cyclophosphamidum (dose 1g) - 4000 pieces2. Cyclophosphamidum (dose 200 mg) - 150 piecesThe detailed description of the subject of the contract is attached as Appendix 1a to the specification. The subject of the order is delivery:1. Mitoxantronum (dose 2 mg/ml; 10 ml) - 160 piecesDetailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1. Irinotecanum (dose 40 mg) - 1300 pieces2. Irinotecanum (dose 100 mg) - 1500 pieces3. Irinotecanum (300 mg) - 2300 pieces4. Irinotecanum (dose 500 mg) - 900 piecesThe detailed description of the subject of the contract is included in Annex 1a to the specification. The subject of the order is delivery:1. Plerixaforum (dose 20 mg/ml; 1 vial 24 mg/1.2 ml) - 60 piecesA detailed description of the subject of the order is attached as Appendix 1a to the specification. The subject of the order is the delivery of:1.Calcii folinas (dose 10 mg/ml; for purchase: 10 ml, 20 ml, 50ml, 100ml) - 7000 doses of 100mgA detailed description of the subject of the order can be found in Appendix 1a to the specification. The subject of the contract is the delivery of:1.Mitotanum (dose 0.5 g x 100 tabl) - 360 packages. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the contract is the delivery of:1.Posaconazolum (dose 40 mg/ml; 105ml) - 500 piecesDetailed description of the subject of the contract is attached as Appendix 1a to the specification. The subject of the contract is the delivery of: 1.Pregabalinum (dose 75 mg) - 50 400 pieces2.Pregabalinum (dose 150 mg) - 10 080 piecesDetailed description of the subject of the contract is attached as Appendix 1a to the specification. The subject of the contract is the delivery of:1.Tacrolimus (dose 0,75 mg) - 1200 pieces2. Tacrolimus (dose 1 mg) - 1200 pieces3. Tacrolimus (dose 4 mg) - 1200 piecesThe detailed description of the subject of the contract is attached as Appendix 1a to the specification. The subject of the contract is the delivery of:1.Aripiprazolum (400 mg dose) - 40 piecesDetailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the contract is the delivery of: 1. Methylprednisolonum (dose 1000 mg) - 2 300 packages A detailed description of the subject of the contract is attached as Appendix 1a to the specification. The subject of the contract is the delivery of: 1.Methylprednisolonum (dose 1000 mg) - 150 packages. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1.Amisulpridum 1200 pieces, 2.Amisulpridum-5000 pieces, 3.Amisulpridum 1200 pieces, 3.Amisulpridum 1200 pieces. Amoxicillinum - 10 800 pcs., Amoxicillinum - 40 pcs., Azathioprinum - 10 800 pcs., Betaxolum - 7 40 pcs. Chlorprothixeni hydrochloride - 9000 pcs, Cyclophosphamidum - 2500 pcs. Flupentixolum - 1000 pieces, 11 Furosemidum - 70 200 pieces. Glucagoni hydrochloridium - 60 pieces, 13. Desmopressinum - 1 620 pieces, 14. Desmopressinum - 1 620 pieces, 15. Dorzolamidum - 50 pieces, 16. Fenoteroli hydrorobromidum + Ipratropy bromidum - 8 300 pieces, 17.Fluoxetinum- 18000 pieces, 18.Goserelina- 20 pieces, 19.Haloperidoli decanoas - 360 pieces, 20.Ipratropii bromidum-1600 pieces, 21.Moclobemidum -600 pieces. 22.Octreotidum-500pcs, 23.Progesteronum* - 6000pcs, 24.Progesteronum*-3000pcs, 25.Progesterone - 1800pcs. 26 Rifampicinum-1500 pcs, 27 Ranitidinum 16200 pcs. 28.Sulfamethoxazolum+ Trimethoprimum - 4500 pcs. 29th Quetiapinum - 64200 pcs, 30th Valsartanum-5040 pcs, 31th Valsartanum-3360 pcs. Candesartanum cilexetilum-1512 pcs., 33rd elimination diet, milk modified for infants with small and very small birth weight -200 pcs. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1. Insulinum humanum (dose of 100 IU/ml; 3 ml) - 2600 pieces, 2. Insulinum humanum (dose of 100 IU/ml; 10 ml) - 1000 piecesA detailed description of the subject of the contract is attached as Appendix 1a to the specification. The subject of the contract is the delivery of: 1. Fentanylum (dose of 12 mcg / h)- 200 pcs. 2. Fentanylum* (dose 25 mcg / h) - 1100 pcs. 3. Fentanylum (dose 50 mcg / h) -900 pcs. 4. Fentanylum (dose 75 mcg / h) - 450 pcs. Fentanylum (dose 100 mcg / h) -300 pcs. Methadoni hydrochloride (dose 1 mg/ml;20 ml) -20 pcs. Methylphenidati hydrochloride (dose 18 mg) -2700 pcs. Sulfentanilum (dose 5 mcg/ml; 10 ml) - 50 pcs. 9. Fentanylum (dose 0,05 mg/dose; 1 bottle 1,8 ml (10 doses) -50 op. Fentanylum (dose 0,1 mg/dose; 1 bottle 2,9 ml (20 doses) - 50 op. 11 Fentanylum (dose 0.2 mg/dose; 1 bottle 5.0 ml (40 doses) - 8 op.cit. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the contract is the delivery of: 1. Estazolamum (dose 2 mg) - 34 200 pieces, 2. Midazolamum (dose 15 mg) - 600 pieces. Midazolamum (dose 7,5 mg) - 11 000 pcs. Phenobarbitalum (dose 100 mg) - 1500 pcs, 5. Zolpidem (dose 10 mg) - 6200 pcs. Zopiclonum (dose 7.5 mg) - 43 200 pcs. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the order is delivery of: 1. Nadroparinum calcicum (dose 11 400 IU/ AXa/0,6 ml) - 36 op. 2. Nadroparinum calcicum (dose 15 200 IU/ AXa/0,8 ml) - 36 op. Nadroparinum calcicum (dose 19 000 IU/ month AXa/ml) - 18 op.m. A detailed description of the subject matter of the contract is included in Appendix 1a to the specification. The subject of the contract is the delivery of: 1. Diazepamum (dose 2mg) -7000 pcs. Diazepamum (dose 5 mg) - 30 600 pcs., 3. Nitrazepamum (dose 5 mg) - 9000 pcs. A detailed description of the subject of the order is attached as Appendix 1a to the specification. The subject of the contract is delivery of: 1. Dikalii clorazepas (dose 5mg)-18000 pieces, 2. Dikalii clorazepas (dose 10 mg) - 10 800 pieces. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the order is delivery of: 1. Midazolamum (dose of 5 mg/ml or 5 mg/2 ml) - 9000 pieces, 2. Midazolamum (dose of 15 mg/2 ml or 15 mg/3 ml) - 2700 pieces. A detailed description of the subject of the order can be found in Appendix 1a to the specification. The subject of the order is delivery of: 1. Nalbuphini (dose 10 mg/ml; 2 ml) - 2000 pcs. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1. Voriconazole (dose 200 mg) - 4500 pcs. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the contract is the delivery of: 1. Metronidazolum (dose 5mg/ml; 100ml) - 80 000 pieces A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the order is delivery of: 1 Atosiban (dose 6.75 mg/0.9 ml) - 300 pieces, 2 Atosiban (dose 37.5 mg/5 ml) - 1800 pieces. A detailed description of the subject of the order is contained in Annex 1a to the specification. The subject of the contract is the delivery of: 1.Torasemidum (dose 5 mg/ml; 4ml) - 32 000 pieces A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the contract is the delivery of: 1.Cefazolinum (dose 1g) - 42 000 pieces A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the order is delivery of: 1.Iohexolum (dose 647 mg/ml, 20 ml) - 3 000 pieces A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the contract is the delivery of: 1. Metamizolum natricum (dose 0.5 g/ml; 5 ml) - 54 000 pieces. Metamizolum natricum* (dose 0.5 g/ml; 2 ml) - 54 000 pcs. A detailed description of the subject matter of the contract is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1. Metamizolum natricum (dose 0.5 g/ml; 5 ml) - 13 500 pcs. Metamizolum natricum (dose 0.5 g/ml; 2 ml) - 13 500 pcs. A detailed description of the subject matter of the contract is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1.Ciclosporinum (dose 50 mg/ml) - 8000 pcs. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1.Metoprololi succinas (dose 25 mg) - 25 000 units, 2.Metoprololi succinas (dose 50 mg) - 37 800 units. A detailed description of the subject of the contract is contained in Annex 1a to the specification. The subject of the order is delivery of: 1. Dobutaminum (dose 50mg/1 ml, 5 ml or 250mg) - 10 400 pcs. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1. Theophyllinum (dose 1.2 mg/ml; 250 ml) - 1 200 pcs. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the contract is the delivery of: 1. Acetazolamdum - 3300 pieces, 2. Acenocoumarolum - 900 pieces, 3. Acidum acetylsalicylicum - 108000 pieces, 4. Acidum ascorbicum, Ferrosi sulfas-9000 pieces. 5. Acidum lipoicum -400 pcs. Alcohol polyvinilicus - 200 op., magnesium alginate, symmetry, fructose, xanthan gum, D-panthenol, sodium carbonate, sodium hydroxide - 120 pcs, Baclofenum - 6000 pcs., Baclofenum - 9. Baclofenum - 3000 pcs., 10. Carbacholum - 1200 pcs., 11. Chlortalidonum -2200 pcs., 12. Desmopressini acetas - 80 pcs., 13. Escitalopram-12000 pcs. Etamsylatum - 21600 pcs, 15 Flunarizinum - 300 pcs, 16 Ibuprofen - 40 pcs, 17 Itopridi hydrochloridium-11000 pcs, 18 Lamotriginum - 2300 pcs, Liraglutidium - 80 pcs, 20 Lactase - 56,9 %, glycerol (concentration feedstock), water, potassium chloride (stabilising feedstock) - 100 pcs, 21.Lamotriginum - 6600 pcs. 22nd Magnesium hydroaspartas-41000 pcs. 23.Memantini-1120 pcs., 24.Metamizolum natricum-34200 pcs., 25.Methyldopum-30000 pcs. 26.Moxifloxacinum-300 pcs. 27 Pentoxifyifyllinum-2100 pcs., 28 Phenytoinum-1,000 pcs., 29 Salbutamol-5400 pcs. 30 Sodium Butyrate-900 pcs, 31 Tetracyclini hydrochloride-640 pcs, 32 Tocopherolum-200 pcs, 33 Tramadoli hydrochloride-15000 pcs, 34 Tramadoli hydrochloride-+ Paracetamolum-64000 pcs, 35 Verapamilum-3600 pcs, Basic bismuth gallusan, bismuth oxide, bismuth oxide, bismuth oxyodogalusan, resorcin, boric acid, zinc oxide, Peru balsam - 1500 pcs, 37 Zofenopril* - 2800 pcs, 38 Zofenopril* - 1540 pcs. A detailed description of the subject of the contract is given in Appendix 1a to the specification. The subject of the order is delivery of: 1. Lidocaini hydrochloride (dose 100 mg/g; 38 g) - 400 pieces, 2. Lidocaine applicator (dose 200 pieces/op) - 50 op., 3. Agent for disinfecting skin and mucous membranes and before surgical procedures - 60 pieces, 4. Levomepromazinum (dose 25 mg) - 4500 pieces. A detailed description of the subject of the order is attached as Annex 1a to the specification. The subject of the order is delivery of: 1. Oxytetracyclini hydrochloride + Polymyxinum B sulfas + Hydrocortisoni acetas (dose (5 mg + 10000 IU + 15 mg)/ml, 5 ml) - 60 pcs. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1. Prasugrel (dose 10 mg) - 280 pcs. A detailed description of the subject of the contract is attached as Appendix 1a to the specification. The subject of the contract is delivery: 1. Alteplasum (dose 10 mg) - 290 pcs. Alteplasum (dose 20 mg) - 250 pcs. Alteplasum (dose 50 mg) - 250 pcsDetailed description of the subject of the contract is included in Annex 1a to the specification. The subject of the contract is delivery of: 1. Ceftriaxonum (dose 1g) - 81 000 pcs. 2. Ceftriaxonum (dose 2g) - 18 000 pieces A detailed description of the subject of the contract is included in Annex 1a to the specification. The subject of the contract is delivery of: 1. Prothrombinum multiplex (dose 500 or 600 c.u.) - 450 Op. The detailed description of the subject of the contract is attached as Appendix 1a to the specification. The subject of the order is delivery of: 1. Levetiracetamum (dose 100 mg/ml; 5 ml) - 2000 pcs. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the order is delivery of: 1.Atropini sulfas (dose 10 mg/ml, 5 ml)-80 pieces, 2.Clemastinum (dose 1 mg) - 8700 pieces, 3.Clemastinum (dose 2 mg/2 ml) - 18400 pieces, 4.Haloperidolum (dose 5 mg/1 ml) - 6500 pieces, 3.Clemastinum (dose 2 mg/2 ml) - 18400 pieces, 4.Haloperidolum (dose 5 mg/1 ml) - 6500 pieces. 5.Haloperidolum (dose 5 mg)-7500 pcs. Haloperidolum (dose 1 mg) - 26000 pcs, Calcium chloridem (dose 150 mg/ml, 20 ml) - 90000 pcs, Metronidazolum (dose 500 mg) - 600 pcs, Propranolols hydrochloridem* (dose 10 mg) - 15000 pcs. Propranololi hydrochloride (40 mg dose) -4500 pcs. A detailed description of the subject matter of the contract is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1.Oxycodoni hydrochloridm (dose 10 mg/ml; 1 ml) - 30000 pieces, 2.Oxycodoni hydrochloridm (dose 20 mg/ml; 2 ml) - 66000 pieces. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the order is delivery of: 1. Iopromidum (dose (768.86 mg/ml) 200 ml) - 500 pcs. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the order is delivery of: 1. Clioquinolum +Flumetasonum (dose (30 mg+ 0.2 mg)/g- 230 pcs., 2. Fludrocortisoni acetas (dose 1 mg/g, 3 g) - 700 pcs. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1. Calcii glubionas (dose 9 mg Ca2+/ml; 10 ml) - 15000 pcs. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the order is delivery of: 1. Tobramycinum (dose 3 mg/ml, 80 ml) - 600 pcs, 2. Tobramycinum (dose 3 mg/ml, 120 ml) - 200 pcs. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the order is delivery of: 1. Belladonnae extractum siccum + Papaverinum (dose (15 mg + 40 mg)/1,5 g)- 800 pcs., 2. Dihydroxyaluminii natrii carbonas (dose 340 mg/5 ml, 250 ml) - 1800 pcs, Levetiracetamum (dose 100 mg/ml, 300 ml) - 40 pcs, Levetiracetamum (dose 101 mg/ml, 150 ml) - 110 pcs, 5. Phenoxymethylpenicillinum kalicum* (dose 1 500 000 IU) - 180 pcs, Phenoxymethylpenicillinum kalicum (dose 1 000 000 IU) - 660 pcs, 7 Tobramycinum (dose (3 mg/ml) - 5 ml) - 360 pcs, 8 Trazodoni hydrochloridem (dose 300 mg) - 600 pcs, 9 Trazodoni hydrochloridem (dose 150 mg) - 1080 pcs, Trazodoni hydrochloridm (dose 75 mg) - 32400 pcs., 11 Trazodoni hydrochloridm* (dose 150 mg) - 10800 pcs. A detailed description of the subject of the contract is included in Annex 1a to the specification. The subject of the order is delivery of: 1. Glyceroli trinitras (dose 1 mg/ml; 10 ml or 2 mg/ml; 5 ml) - 10000 pcs. A detailed description of the subject of the order is contained in Appendix 1a to the specification. The subject of the contract is delivery of: 1 g P granules: contains 738 mg cholestramine, 200 mg pectin, 54 mg sucrose and 1.8 mg sorbic acid and flavouring substances (1 sachet 4 g) - 4000 sachetsA detailed description of the subject of the contract is attached as Appendix 1a to the specification. The subject of the order is delivery of: 1. Clonidine (0.15 mg/1 ml dose) - 90 pieces, 2. Isoprenaline (0.2 mg/ml;1 ml dose) - 500 pieces, 3. Sodium perchlorate (0.3 g/1 ml dose, 40ml) - 80 pieces. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the order is delivery of: 1. Phenobarbital (dose 0.04g) - 1000 pcs. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the order is delivery of: 1. Bactericidal, sterile foam dressing impregnated with polyhexamethylene miganide 0,5 % - 1800 pcs, 2. Bactericidal, sterile foam dressing impregnated with polyhexamethylene miganide 0,5 % - 1500 pcs. A detailed description of the subject of the order is contained in Annex 1a to the specification. The subject of the order is delivery: 1. Heparine (dose 500 U.I./5 ml) - 4000 pcs. A detailed description of the subject of the order is included in the attachment No. 1a to the specification. The subject of the order is delivery of: 1. Hemostatic gelatine sponge - 3000 pieces, 2. Hemostatic gelatine sponge - 180 pieces, 3. Hemostatic gelatine sponge - 2700 pieces Detailed description of the subject of the order is attached as Appendix 1a to the specification. The subject of the contract is the delivery of: 1. Polysaccharide hemostatic system highly purified, maximum biodegradation time after application up to 8 days, biocompatible, apirogenic, with documented anti-growth action, hemostatic and anti-growth action - confirmed by CE certificate (1g) - 150 pcs, 2. polysaccharide hemostatic system, highly purified, maximum biodegradation time after application up to 8 days, biocompatible, apirogenic; with documented anti-growth action; hemostatic and anti-growth action - CE* certified (3g) - 250 pcs, 3. polysaccharide hemostatic system, highly purified, maximum biodegradation time after application up to 8 days, biocompatible, apirogenic; with documented anti-growth action; hemostatic and anti-growth action - CE(5 g) certified - 90 pcs, 4. polysaccharide hemostatic system, highly purified, maximum biodegradation time after application up to 8 days, biocompatible, apirogenic; with documented anti-growth action; hemostatic and anti-growth action - CE certified (9g) -20 pcs, Single-use sterile applicator compatible with products from item 1.2 intended for laparoscopic procedures, internal catheter with a length of 33 cm and rigid guide with a length of 38 cm; equipped with a two-part handle (33 cm and 38 cm) - 510 pcs. A detailed description of the subject of the contract is included in Appendix 1a to the specification. The subject of the order is delivery of: 1. sterile dressing made of calcium alginate fibers with addition of silver for infected wounds - 1100 pcs, 2. sterile dressing made of calcium alginate fibers with addition of silver for infected wounds - 2000 pcs, 3. sterile dressing made of calcium alginate fibers with addition of silver for infected wounds - 1500 pcs. A detailed description of the subject of the order is included in Annex 1a to the specification. The subject of the contract is delivery of: 1. polyester dressing containing laboratory sterilized live cultures of Lucilia sericata larvae - 100 items, 2. polyester dressing containing laboratory sterilized live cultures of Lucilia sericata larvae - 100 items, 3. polyester dressing containing laboratory sterilized live cultures of Lucilia sericata larvae - 100 items. A detailed description of the subject of the contract is attached as Annex 1a to the specification. The subject of the order is the delivery of: 1. complete diet, hyperkaloric (1.5 kcal/ml), normalized protein, poor-residuous, in the form of a milk drink, for nutritional treatment by the duct - 8000 pcs., 2. complete diet, hyperkaloric (1.5 kcal/ml), rich protein, non-residuous, in the form of a milk drink, for nutritional treatment by the duct - 2000 pcs, 3. complete diet in patients with diabetes, hyperkaloric (1.5 kcal/ml), protein-rich, richer, in the form of a milk beverage, for dietary treatment by the gastrointestinal tract - 3600 pcs, 4. complete diet for liver diseases, hypercaloric (1.3 kcal/ml), normalized protein, richer-resistant, in the form of a milk beverage, for nutritional treatment by the digestive tract - 1500 pcs. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the order is delivery of: 1. glucose syrup, casein (from milk), sucrose, milk fat, medium chain triglycerides, corn oil, emulsifier (soy lecithin), minerals, vitamins, choline dihydrate - 600 pcs. A detailed description of the subject of the order is included in Appendix 1a to the specification. The subject of the contract is delivery of: 1. Dietary foodstuff for special medical purposes for infants from the first hours of life; one portion: maltodextrin, bacterial scapes: Lactobacillus rhamnosus KL53A, Bifidobacterium breve PB04, ascorbic acid - 40 600 pcs. A detailed description of the subject matter of the contract is attached as Appendix 1a to the specification.
- Opportunity closing date
- 17 July 2019
- Value of contract
- £1m-5m
About the buyer
- Address
- Szpital Uniwersytecki w Krakowie ul. Kopernika 36 Kraków 31-501 Poland
- Contact
- kkowalczyk@su.krakow.pl
The deadline to apply for this opportunity has passed.
Visit the
opportunities page
to find another.